BIOPHTA received the Gold medal of the Boston Biotechnology summit from the hands of the summit director, Dr Shahin GHARAKHANIAN. BIOPHTA stood out amongst a global panel of prestigious biotech startups and won the first prize of the competition.
After the US Academy of Medicine, this is the second award received from a renowned US institution.
Innov’UP leader is a Deep Tech startup competition which is part of the French national plan PIA4 (programme d’investissements d’avenir) and is co-funded by the region Île-de-France.
BIOPHTA has been awarded €500,000 non-dilutive funding to support the next steps of its glaucoma program. This grant will allow the company to accelerate the industrial transfer of the manufacturing of its “Thiomer” biopolymers.
i-Lab is a highly selective national startup competition rewarding early-stage Deep Tech projects. This very prestigious trophy also comes with a prize of €350,000 in subsidies to support the initial R&D phases of the company.
i-Lab is an important recognition of the disruptiveness of BIOPHTA’s technology by the French Ministry of Research.
BIOPHTA has been awarded by the Healthy Longevity Global Competition organized by the American Academy of Medicine.
This Competition kickstarts innovation to support healthy longevity through a series of awards and money prizes and rallies the world’s greatest minds to achieve what may at first seem an impossible goal.
BIOPHTA has been awarded by the Headstart program and granted a €50,000 money prize. This program is funded by EIT Health, which is a body of European Union.
This award recognizes BIOPHTA as one of the most promising healthcare startups in the most influential European healthtech ecosystem.